Abstract

A new US president and an international financial crisis demonstrate how quickly the world can change. But they also serve to emphasize the resilience of the industry that we are all involved in. At times of crisis, investing in health is always an attractive option. Population explosions, demographic shifts and sophisticated diagnoses mean that healthcare organizations and pharmaceutical companies continue to prosper. Moreover, when economic fears grip the world of private enterprise, jobs in the public sector acquire a reassuring glow of security.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call